BioTech & SmartPharma

Sector challenges

Sector challenges

The Biotech and SmartPharma sectors continue to develop rapidly. They look set to bring major advances in personalized therapies, early diagnosis, predictive medicine and optimizing the drug value chain – and considerable potential for improving human health and solving complex medical problems.

R&D

Drug Discovery

Biomanufacturing

Technology Platforms

Therapeutic Innovations

Life Science Tools

Biotech

Gene Therapy

Cell Therapy

Biosensors

Immunotherapies

Biopharmaceuticals

Performances

BioTech & SmartPharma performance in France in 2022

800

companies

x6

BioTech companies since 2002

3

3 R&D products per BioTech

32

employees on average per company

Our services

Discover how to transform your ambitions into success

Startups

Midcaps & corporations

Local collectivities

Collaboration with WILCO

Companies shaping BioTech & SmartPharma

Your contact

Your contacts at WILCO

Amele Seghaier

Business Manager

Inès Pouradier Duteil

Program Manager

Entrepreneur Mentors

Entrepreneur Mentors for
BioTech & SmartPharma

Yann Barrault

Alain Clergeot

Joël Crouzet

Eric Garnier

Mirella Laguerre Charpentier